John R. Oscarson
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John R. Oscarson.
The Journal of Antibiotics | 1990
John P. Dirlam; Annette M. Belton; Jon Bordner; Walter P. Cullen; Liang H. Huang; Yasuhiro Kojima; Hiroshi Maeda; Hiroyuki Nishida; Satoshi Nishiyama; John R. Oscarson; Anthony Paul Ricketts; Tatsuo Sakakibara; Junsuke Tone; Katsuhitsu Tsukuda
A new polyether antibiotic CP-82,009 (C49H84O17) was isolated by solvent extraction from the fermentation broth of Actinomadura sp. (ATCC 53676). Following purification by column chromatography and crystallization, the structure of CP-82,009 was elucidated by spectroscopic (NMR and MS) methods. The absolute stereochemistry was determined by a single crystal X-ray analysis of the corresponding rubidium salt. CP-82,009 is among the most potent anticoccidial agents known, effectively controlling the Eimeria species that are the major causative agents of chicken coccidiosis at doses of 5 mg/kg or less in feed. It is also active in vitro against certain Gram-positive bacteria, as well as the spirochete, Serpulina (Treponema) hyodysenteriae.
Journal of Industrial Microbiology & Biotechnology | 1988
Walter P. Cullen; Walter D. Celmer; Larry R. Chappel; Liang H. Huang; Mark T. Jefferson; Masaru Ishiguro; Hiroshi Maeda; Satoshi Nishiyama; John R. Oscarson; Riichiro Shibakawa; Junsuke Tone
SummaryCP-61,405 (C26H29N2O7Na) is a novel polycyclic pyrrolether antibiotic produced by a new species,Streptomyces routienii Huang sp. nov. (ATCC 39446). Recovery, fractionation and purification were achieved using standard procedures. The crystalline form includes the CP-61,405 sodium salt, m.p. 334–335°C, [α]D25°C+315°C (c=1, chloroform). The structure is shown below. CP-61,405 was co-produced with the polycyclic ether antibiotics salinomycin and epi-17-deoxy-(0–8)-salinomycin. It exhibited activity in vitro against gram-positive and anaerobic bacteria, efficacy against poultry coccidia and stimulation in vitro of propionic acid production.
Journal of Industrial Microbiology & Biotechnology | 1990
John P. Dirlam; Annette M. Belton; Jon Bordner; Walter P. Cullen; Liang H. Huang; Yasuhiro Kojima; Hiroshi Maeda; Satoshi Nishiyama; John R. Oscarson; Anthony Paul Ricketts; Tatsuo Sakakibara; Junsuke Tone; Mamoru Yamada
SummaryA new polyether antibiotic CP-82,996 (C50H86O16) was isolated by solvent extraction from the fermentation broth ofActinomadura sp. (ATCC 63764). Following purification by silica gel column chromatography and crystallization, the structure of CP-82,996 was determined by a single crystal X-ray analysis. The structure is closely related to monensin, but is unique in that it contains two sugar groups, whereas monensin has none. The1H and13C NMR chemical shifts and assignments for CP-82, 996 were elucidated, and they were compared with those determined previously for monensin. CP-82,996 is active against certain Gram-positive bacteria, and is a very potent anticoccidial agent. It effectively controlled chicken coccidiosis caused by severalEimeria species at 5–10 ppm in feed, and is 10–20 times more potent than monensin.
Journal of Industrial Microbiology & Biotechnology | 1990
Walter P. Cullen; Jon Bordner; Liang H. Huang; Peter M. Moshier; John R. Oscarson; Laura Presseau; Richard Ware; Earl B. Whipple; Yasuhiro Kojima; Hiroshi Maeda; Satoshi Nishiyama; Junsuke Tone; Katsuhitsu Tsukuda; Kelvin Scott Holdom; John C. Ruddock
SummaryCP-60,993, 19-epi-dianemycin, is a novel polycyclic ether antibiotic produced byStreptomyces hygroscopicus ATCC 39305. Fermentation recovery, purification and crystallization were achieved using standard procedures. CP-60,993 was characterized as a monocarboxylic acid. Elemental analysis suggested a molecular formula of C47H78O14 for the free acid and C47H77O14 Na for the sodium salt. Crystalline form CP-60,993 sodium salt shows the following properties: m.p. 193∼205°C, E1 cm1%=157 at 232 nm, [α]D25°C+11.0 (c 1, methanol). The structure, determined by MS, PMR and CMR, differs from dianemycin only in the stereochemistry at position 19. This was confirmed by X-ray crystallography carried out on the rubidium salt of CP-60,993. It exhibited activity in vitro against Gram-positive and anaerobic bacteria, efficacy againstEimeria coccidia in vivo in poultry, and stimulation in vitro of rumen propionic acid production.
Archive | 1979
Walter D. Celmer; Walter P. Cullen; John R. Oscarson; Liang H. Huang; Riichiro Shibakawa; Junsuke Tone
Archive | 1977
Walter D. Celmer; Walter P. Cullen; Charles E. Moppett; John R. Oscarson; Liang H. Huang; Riichiro Shibakawa; Junsuke Tone
The Journal of Antibiotics | 1989
John R. Oscarson; Jon Bordner; Walter D. Celmer; Walter Patrick Cullen; Liang H. Huang; Hiroshi Maeda; Peter M. Moshier; Satoshi Nishiyama; Laura Presseau; Riichiro Shibakawa; Junsuke Tone
The Journal of Antibiotics | 1991
John P. Dirlam; Walter P. Cullen; Liang Hsiung Huang; Theodore H. Nelson; John R. Oscarson; Laura Presseau-Linabury; Edward J. Tynan; Earl B. Whipple
The Journal of Antibiotics | 1989
John P. Dirlam; Annette M. Belton; Shang-Poa Chang; Walter P. Cullen; Liang H. Huang; Yasuhiro Kojima; Hiroshi Maeda; Satoshi Nismyama; John R. Oscarson; Tatsuo Sakakibara; Junsuke Tone; Mamoru Yamada; Gayle K. Schulte
Archive | 1977
Walter D. Celmer; Walter P. Cullen; Charles E. Moppett; John R. Oscarson; John B. Routien; Riichiro Shibakawa; Junsuke Tone